HM Payson & Co’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Buy
22,700
+288
+1% +$162K 0.16% 86
2026
Q1
$12.6M Buy
22,412
+616
+3% +$395K 0.18% 86
2025
Q4
$14.7M Sell
21,796
-349
-2% -$238K 0.21% 76
2025
Q3
$14.1M Buy
22,145
+545
+3% +$331K 0.2% 72
2025
Q2
$11.6M Sell
21,600
-255
-1% -$122K 0.18% 74
2025
Q1
$9.18M Sell
21,855
-170
-0.8% -$73.8K 0.16% 80
2024
Q4
$9.11M Sell
22,025
-1,328
-6% -$582K 0.15% 81
2024
Q3
$11.8M Sell
23,353
-952
-4% -$462K 0.2% 78
2024
Q2
$11.8M Sell
24,305
-900
-4% -$452K 0.22% 73
2024
Q1
$13.6M Sell
25,205
-1,309
-5% -$715K 0.25% 74
2023
Q4
$14.7M Buy
26,514
+10
+0% +$4.7K 0.3% 65
2023
Q3
$11.6M Buy
26,504
+655
+3% +$327K 0.27% 67
2023
Q2
$13M Sell
25,849
-131
-0.5% -$62.8K 0.29% 64
2023
Q1
$13M Sell
25,980
-1,484
-5% -$710K 0.31% 61
2022
Q4
$11.2M Sell
27,464
-161
-0.6% -$62.5K 0.28% 67
2022
Q3
$9M Sell
27,625
-70
-0.3% -$25.7K 0.25% 70
2022
Q2
$9.71M Sell
27,695
-2,161
-7% -$881K 0.25% 71
2022
Q1
$16.3M Buy
29,856
+54
+0.2% +$28.4K 0.37% 62
2021
Q4
$19.6M Buy
29,802
+350
+1% +$220K 0.43% 60
2021
Q3
$18.3M Sell
29,452
-8
-0% -$5.38K 0.45% 57
2021
Q2
$18.6M Sell
29,460
-8
-0% -$4.42K 0.45% 58
2021
Q1
$14.4M Buy
29,468
+120
+0.4% +$60.1K 0.38% 63
2020
Q4
$14.7M Sell
29,348
-899
-3% -$402K 0.41% 64
2020
Q3
$11.9M Sell
30,247
-151
-0.5% -$55.8K 0.37% 63
2020
Q2
$10M Sell
30,398
-200
-0.7% -$57.9K 0.34% 66
2020
Q1
$7.41M Sell
30,598
-3,624
-11% -$946K 0.29% 72
2019
Q4
$8.94M Buy
34,222
+54
+0.2% +$14.2K 0.29% 72
2019
Q3
$9.29M Buy
34,168
+3,190
+10% +$888K 0.33% 69
2019
Q2
$8.53M Sell
30,978
-467
-1% -$115K 0.31% 69
2019
Q1
$7.03M Buy
+31,445
New +$6.49M 0.27% 78
2018
Q4
Sell
-21,519
Closed -$5.37M 234
2018
Q3
$5.37M Sell
21,519
-1,930
-8% -$468K 0.24% 80
2018
Q2
$5.11M Sell
23,449
-100
-0.4% -$20.6K 0.22% 85
2018
Q1
$4.51M Sell
23,549
-20
-0.1% -$3.69K 0.19% 98
2017
Q4
$3.69M Buy
23,569
+1,563
+7% +$246K 0.15% 111
2017
Q3
$3.42M Buy
22,006
+1,035
+5% +$164K 0.15% 109
2017
Q2
$3.38M Sell
20,971
-120
-0.6% -$19.5K 0.15% 107
2017
Q1
$3.26M Buy
21,091
+85
+0.4% +$11.7K 0.15% 107
2016
Q4
$2.46M Sell
21,006
-150
-0.7% -$17.1K 0.12% 126
2016
Q3
$2.38M Sell
21,156
-2,400
-10% -$253K 0.12% 128
2016
Q2
$2.19M Sell
23,556
-220
-0.9% -$18.9K 0.11% 128
2016
Q1
$1.86M Sell
23,776
-400
-2% -$28.8K 0.1% 133
2015
Q4
$1.76M Buy
24,176
+1,632
+7% +$116K 0.09% 146
2015
Q3
$1.67M Hold
22,544
0.09% 145
2015
Q2
$1.45M Sell
22,544
-100
-0.4% -$6.92K 0.07% 159
2015
Q1
$1.75M Buy
22,644
+500
+2% +$38.9K 0.09% 147
2014
Q4
$1.64M Hold
22,144
0.08% 150
2014
Q3
$1.3M Hold
22,144
0.07% 156
2014
Q2
$1.48M Sell
22,144
-220
-1% -$14K 0.08% 150
2014
Q1
$1.36M Sell
22,364
-300
-1% -$17.9K 0.07% 149
2013
Q4
$1.21M Sell
22,664
-800
-3% -$42.1K 0.06% 154
2013
Q3
$1.17M Sell
23,464
-2,420
-9% -$116K 0.07% 153
2013
Q2
$1.16M Buy
+25,884
New +$1.13M 0.07% 150

Other funds holding IDXX

HM Payson & Co's IDXX Position: Q2 2026 in Review

HM Payson & Co increased its Idexx Laboratories (IDXX) stake by 1.3% in Q2 2026, buying an estimated $162K and bringing the position to 22,700 shares worth $12M. The position accounts for 0.16% of the portfolio, ranked #86.

HM Payson & Co first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.6M in Q4 2021. 1,301 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • HM Payson & Co held 22,700 shares of Idexx Laboratories worth $12M as of Q2 2026.
  • HM Payson & Co bought 288 Idexx Laboratories shares in Q2 2026, an estimated $162K.
  • Idexx Laboratories made up 0.16% of HM Payson & Co's portfolio in Q2 2026, its #86 holding.
  • HM Payson & Co first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • HM Payson & Co's Idexx Laboratories position peaked at $19.6M in Q4 2021.
  • 1,301 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.